Anthropic acquires biotech startup exploring AI-led drug development

European Pharmaceutical Review2026-10-30T11:01:00+00:00

No comments

Anthropic has acquired Mithril Medicine, a biotech startup that used its Claude AI models to coordinate an experimental drug development programme for muscular dystrophy.

Topics

No comments

News
Boehringer and Microsoft joint venture targets digital twins for clinical development

2026-10-23T11:47:00Z
Article
Rethinking how investigator oversight is evidenced in clinical trials

2026-10-23T09:00:00Z

Tracy Vanderslice
Opinion
Manufacturing the route: oral and injectable drug delivery

2026-10-21T09:45:00Z

Jennifer Gattari
News
European Pharmacopoeia launches working party for 3D-printed medicines

2026-10-13T11:20:00Z
Article
Building the pharmaceutical facility that is ready for change

Sponsored by Rockwell Automation, Andy Lynam
Article
European Pharmaceutical Review Issue 2 2026

2026-09-28T12:56:00Z

Sponsored by ACC

No comments yet

You're not signed in.

Only registered users can comment on this article.

Partner content

Article
Closing the data integrity gap in pharmaceutical quality control

2026-08-25T08:09:00

Sponsored by LabVantage
Report
The next era of pharmaceutical innovation: from emerging technologies to scalable solutions

2026-09-23T12:28:00

Sponsored by Pfizer CentreOne and Lubrizol Advanced Materials Europe BV, European Pharmaceutical Review
Article
Lab 4.0 balance: connected, compliant and ready to integrate

2026-08-20T08:05:00

Sponsored by Sartorius
Article
Large-scale AAV manufacturing for non-rare diseases

2026-10-19T10:02:00

Sponsored by Cytiva
Article
MultiNA II MCE-301: smarter nucleic acid analysis for the modern lab

2026-04-30T10:37:00

Sponsored by Shimadzu
Article
The next frontier in nitrosamine testing: detection and risk assessment in packaging and IV infusion bags

2026-08-27T14:30:00

Sponsored by Waters Corporation

Anthropic acquires biotech startup exploring AI-led drug development

Topics

Related articles

Boehringer and Microsoft joint venture targets digital twins for clinical development

Rethinking how investigator oversight is evidenced in clinical trials

Manufacturing the route: oral and injectable drug delivery

European Pharmacopoeia launches working party for 3D-printed medicines

Building the pharmaceutical facility that is ready for change

European Pharmaceutical Review Issue 2 2026

No comments yet

Only registered users can comment on this article.

Partner content

Closing the data integrity gap in pharmaceutical quality control

The next era of pharmaceutical innovation: from emerging technologies to scalable solutions

Lab 4.0 balance: connected, compliant and ready to integrate

Large-scale AAV manufacturing for non-rare diseases

MultiNA II MCE-301: smarter nucleic acid analysis for the modern lab

The next frontier in nitrosamine testing: detection and risk assessment in packaging and IV infusion bags

More News

UK clinical trial reforms deliver seven-day approval for eligible trial modifications

Pharma’s 2030 outlook: manufacturing, access and supply chain resilience

NEREUS meets Phase III endpoints for GLP-1-related vomiting

Sandoz expands biosimilar pipeline through $322m Henlius deal